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Challenges to body fluid homeostasis can have a profound impact on hypothalamic
regulation of stress responsiveness. Deficiencies in blood volume or sodium
concentration leads to the generation of neural and humoral signals relayed through the
hindbrain and circumventricular organs that apprise the paraventricular nucleus of the
hypothalamus (PVH) of hydromineral imbalance. Collectively, these neural and humoral
signals converge onto PVH neurons, including those that express corticotrophin-
releasing factor (CRF), oxytocin (OT), and vasopressin, to influence their activity and
initiate compensatory responses that alleviate hydromineral imbalance. Interestingly,
following exposure to perceived threats to homeostasis, select limbic brain regions
mediate behavioral and physiological responses to psychogenic stressors, in part, by
influencing activation of the same PVH neurons that are known to maintain body
fluid homeostasis. Here, we review past and present research examining interactions
between hypothalamic circuits regulating body fluid homeostasis and those mediating
behavioral and physiological responses to psychogenic stress.
Keywords: anxiety, stress, oxytocin, angiotensin, hypernatremia, post-traumatic stress disorder, hypothalamic-
pituitary-adrenal axis, paraventricular nucleus
Introduction
Research focused on developing a comprehensive understanding of circuits that mediate anxiety
has been a priority during the past several decades (Griebel and Holmes, 2013). However, lack of
therapeutics for anxiety disorders is largely not indicative of this effort (Dias et al., 2013; Stewart
and Kalueff, 2014). Although recent advancements in technology are fueling new and promising
investigations (Lammel et al., 2014), isolating a treatable anxiolytic pathway in the brain has been
elusive. This may be, at least in part, due to the complexity of treating psychiatric disorders in
general as, unlike many systemic disorders, the inaccessibility of the brain and the intricacies of
its neuronal networks present formidable obstacles to the clear understanding of their origin and
progression (for expansion on this topic see Deisseroth, 2014). Thus, novel creative approaches
to isolating specific circuits as well as a better understanding of how they dysfunction in anxiety
disorders are vital public health concerns. To this end, re-evaluation of the well-characterized
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renin-angiotensin-aldosterone system (RAAS) and the
neuroendocrine systems involving arginine vasopressin
(AVP) and oxytocin (OT) is contributing to new mechanistic
insight into perhaps underappreciated influences on
psychopathology—especially when these systems are considered
as complementary homeostatic pathways that impact the
appropriateness and timing of responses to psychogenic stress.
Mood disorders are often accompanied by dysregulation of
the hypothalamic-pituitary-adrenal (HPA) axis (Arborelius et al.,
1999; Jacobson, 2014) which normally serves to mobilize energy
reserves through glucocorticoid release in cooperation with the
autonomic nervous system (Ulrich-Lai and Herman, 2009). The
efficiency of the stress response is governed by (1) the ability
to successfully integrate multiple lines of central and peripheral
information to reflect a response (Ziegler and Herman, 2002)
and (2) the behavioral adaptation and glucocorticoid feedback
mechanisms responsible for effecting a timely resolution (Keller-
Wood and Dallman, 1984; Watts, 2005). Compelling evidence
suggests that systemic and central mechanisms mediating
body fluid homeostasis substantially impact both of these
parameters.
The physiological stressors of hypotension and hypovolemia
stimulate renin release to catalyze angiotensin-II (Ang-II)
formation and aldosterone (ALDO) availability (Fitzsimons,
1998), as well as AVP release (Yao et al., 2011). These hormones
promote fluid retention to stabilize blood volume and pressure
(Fitzsimons, 1998), but also act in the brain to modulate
behavior and potentiate stress responsiveness (Krause et al.,
2011b) through direct and indirect action in brain regions
that innervate the paraventricular nucleus of the hypothalamus
(PVH; Englemann et al., 2000; Albrecht, 2010). Low plasma
sodium is alleviated by eliminating excess water through diuresis
and AVP inhibition (Wang et al., 2013) as well as by increasing
salt intake and reducing salt excretion. Hypernatremia increases
the pituitary release of AVP and OT to cause renal water
reabsorption and salt excretion (Noda and Sakuta, 2013), but
the central release of these peptides is known to affect distant
forebrain and hindbrain targets (Antunes-Rodrigues et al., 2013)
that also influence anxiety (Knobloch et al., 2012; Neumann and
Landgraf, 2012; Benarroch, 2013; Frazier et al., 2013). Together
these signals represent a constantly fluctuating background upon
which the stress response may be potentiated or inhibited
depending on the magnitude, polarity, and duration of an
osmotic challenge.
The neuroanatomical pathways that govern stress and mood
are ongoing subjects of investigation. While many studies have
focused on either the RAAS or neuropeptide influences on
stress responsiveness separately, a cohesive picture of the specific
central pathways that are modulated on a circuit, cellular, and
molecular basis is lacking. The brain regions and circuits that
govern the habituation, sensitization, and adaptation of the
HPA axis that occur during chronic stress have been well-
characterized (Flak et al., 2009; Herman, 2013) but whether
these circuits and processes are influenced by hydromineral
imbalance have only been tenuously addressed. These particular
aspects of the stress response are vulnerable to deficiencies
or excessive activation of osmoregulatory mechanisms and
are directly related to the dysregulation of corticotrophin
releasing factor (CRF) and glucocorticoid regulation that
are hallmarks of stress-related disorders (de Kloet et al.,
2005). Here we address these outstanding issues through a
review of the literature and explore the scope of influence
and evidence supporting an osmotic component which may
heavily influence the function of hypothalamic stress-responsive
circuits.
The RAAS and Stress Responsiveness
The RAAS plays a major role in the regulation of systemic blood
pressure, urinary sodium excretion, and renal hemodynamics.
In experimental models, stimuli such as pharmacologically
induced vasodilation (Stocker et al., 2000), hypovolemia induced
by polyethylene glycol administration (Stricker and Verbalis,
1986), or hemorrhage (Yamaguchi and Hama, 2011) are potent
activators of the RAAS and elicit thirst. Furthermore, volume
depletion associated with sodium loss provokes a rise in Ang-II
and ALDO levels (Badauê-Passos et al., 2007). These conditions
will be briefly addressed followed by an account of their relevance
to the potentiation of stress responsiveness. Finally, experimental
reports that demonstrate how increased RAAS activity is related
to increased stress-responsiveness and heightened anxiety will be
presented.
Activation of the RAAS
Blood pressure is intrinsically bound to hydromineral balance
and deficiency compels several homeostatic mechanisms to
action. Carotid sinus and aortic baroreceptors decrease tonic
firing frequency in response to a drop in pressure, activating
neurons in the nucleus of the solitary tract (NTS) that
increase sympathetic outflow while decreasing parasympathetic
tone (Fisher and Paton, 2012). If the drop in pressure is
severe, afferent signals from the NTS and forebrain induce
AVP release which acts on vasopressin type 1 receptors
of the vasculature (Aoyagi et al., 2009) and vasopressin
type 2 receptors in the kidney (Sampey et al., 1999) to
promote vasoconstriction and water reabsorption, respectively.
Cardiopulmonary baroreceptors also activate NTS neurons
that increase sympathetic nervous system activity. These
neurons cause rostroventrolateral medulla and intermediolateral
cell column efferents to release norepinephrine onto β1
receptors of the juxtaglomerular apparatus, thereby increasing
renin release and plasma renin activity (PRA) to promote
the synthesis of Ang-II (Hainsworth, 2014). Additionally,
reduced perfusion pressure is sensed by baroreceptors in the
renal vasculature to increase PRA via prostaglandin signaling
(Schweda and Kurtz, 2011). Prostaglandin-mediated renin
release is furthermore induced by a reduction of NaCl circulation
in the renal medulla (Schweda and Kurtz, 2011). Thus,
reduced extracellular fluid volume is monitored by the systemic
vasculature and kidneys to initiate activation of the RAAS as
well as hypothalamic nuclei controlling endocrine release and
autonomic balance.
Increased circulating Ang-II affects both systemic and
centrally-mediated compensatory measures. Ang-II binding to
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angiotensin type 1 (AT1) receptors is a potent vasoconstrictive
stimulus (Fitzsimons, 1998), and activation of AT1 receptors
expressed on the efferent arteriole of the kidney increases
glomerular filtration rate (Kobori et al., 2013) during instances
of low blood pressure. Furthermore, elevated levels of Ang-
II upregulate the synthesis and release of ALDO in the zona
glomerulosa of the adrenal gland (Hattangady et al., 2012).
Aldosterone binds to cytosolic mineralocorticoid receptors
within renal tubular cells of the cortical collecting ducts,
increasing the reabsorption of NaCl and water (Biller et al.,
2001). The effects of Ang-II in the periphery restore extracellular
fluid volume by conserving water and NaCl, allowing normal
function of vital organs. Ang-II accessibility to the brain however,
is blocked by the blood-brain barrier, except for in regions that
have a specialized blood-brain barrier architecture (McKinley
et al., 2003). These regions, termed circumventricular organs
(CVO), allow the brain to sample the immediate systemic
environment through specialized neurons (Duvernoy and Risold,
2007). In particular, the subfornical organ (SFO) and organum
vasculosum of the lamina terminalis (OVLT) are CVOs that
express receptors for Ang-II and ALDO (De Luca et al.,
2013). Activation of AT1 receptors in the core of the SFO
and lateral margins of the OVLT by Ang-II (Sunn et al.,
2003) stimulates a neuronal network with nodes in several
brain regions. The net result of Ang-II induced activation
of this network is the enigmatic behavioral and physiological
phenomenon of thirst (Stricker and Sved, 2000), which is largely
dependent on CVO afferent projections to the median preoptic
nucleus (Hollis et al., 2008), as well as complex regulation of
neuropeptide release (McKinley et al., 2004) and sympathetic
activation (Stocker et al., 2008) designed to complement systemic
function. Moreover, it is now well-established that the brain
is capable of producing all the components of the RAAS
(Phillips and Sumners, 1998; Gomez-Sanchez et al., 2005),
and systemic Ang-II and ALDO elevations may influence the
activity of the local brain RAAS to modulate limbic and
neuroendocrine systems.
In regards to ALDO, its central actions are not restricted by
the blood-brain barrier, but instead, are limited by competition
with glucocorticoids for binding sites (Geerling and Loewy,
2009). Because ALDO circulates at concentrations ∼1000
fold less than glucocorticoids (Bledsoe et al., 2005), most
mineralocorticoid receptors in the brain are not activated
by ALDO. Exceptions include the PVH (Chen et al., 2014);
amygdala and locus coeruleus (Robson et al., 1998); and NTS
(Geerling and Loewy, 2006), where specialized subsets of cells
express both mineralocorticoid receptors and 11β-HSD, making
these areas susceptible to physiological states that increase
circulating Ang-II and ALDO.
In summary, the RAAS is potently activated by hypotension
and reduced extracellular fluid volume and tonicity. Through
multiple sensory mechanisms, body fluid homeostasis is
maintained through cardiovascular and renal signals that
converge on the hypothalamus through CVO and hindbrain
inputs, which in turn, are reciprocally connected to limbic
brain regions controlling mood and affect. Thus, brain
regions controlling mood and affect promote cardiovascular
and endocrine responses to stress through hypothalamic
and hindbrain nuclei that are also sensitive to RAAS
activation. Consequently, RAAS sensitive neuronal networks
are positioned to influence cardiovascular and endocrine
responses to hydromineral imbalance as well as psychological
stressors.
Potentiation of the Stress Response During
Increased RAAS Activity
Stressors can be classified into the two broad categories of
physiological or psychological. Physiological stressors include
those that threaten body fluid homeostasis, and activation
of the RAAS is an example of the body’s attempt to cope
through endocrine, autonomic, and behavioral adjustments.
Stressors that are psychogenic in nature influence anxiety level,
sympathetic tone, and the HPA axis through anticipatory,
memory, and fear-related systems relayed to the hypothalamus
via limbic brain regions (Jankord and Herman, 2008). Although
often unnecessary to the welfare of the individual, coping
mechanisms that respond to psychogenic stressors can include
RAAS activation (Krause et al., 2011b). Both types of stressors
have the potential to activate the HPA axis via stimulation of
PVH parvocellular CRF neurons that project to the median
eminence. The release of CRF into the primary capillary plexus
of the hypothalamo-hypophyseal portal vasculature induces
anterior pituitary adrenocorticotrophin hormone (ACTH)
release. The binding of ACTH to the zona fasciculata layer of
the adrenal gland causes glucocorticoid synthesis and release
into the systemic circulation that bind to GRs throughout the
body to mobilize energy reserves and down-regulate processes
not essential to the stress response. Negative feedback of
glucocorticoid occurs at several levels including the pituitary and
PVH to bring about termination of HPA axis activity.
Exposure to psychogenic stress activates the RAAS in
the absence of threats to hydromineral balance to increase
central and systemic Ang-II (Yang et al., 1993) as well
as the expression of AT1 receptors in the brain (Aguilera
et al., 1995a). Stress-induced up-regulation of AT1 receptor
mRNA occurs in the SFO, anterior pituitary, zona glomerulosa
and medulla of the adrenal gland (Leong et al., 2002),
and on CRF cells in the PVH (Aguilera et al., 1995b).
Similarly, administration of dexamethasone, a GR agonist,
significantly increases AT1 receptor binding in the PVH and
SFO (Shelat et al., 1999). Taken together, these results suggests
that glucocorticoids derived from stress-induced HPA axis
activation may feed forward to increase AT1 receptor expression
to alter sensitivity to centrally released Ang-II. Consistent
with this notion, pretreatment with dexamethasone augments
drinking stimulated by central administration of Ang-II
(Ganesan and Sumners, 1989) and elevated glucocorticoids
accompanied by increased Ang-II release in the PVH reduces
11β-HSD effectiveness resulting in increased pre-autonomic
stimulation (Gabor and Leenen, 2012) and potentiation of
sympathetic activity (de Kloet et al., 2005). Thus, induction
of the HPA axis may interact with an activated RAAS
to sensitize subsequent behavioral and autonomic responses
to hydromineral imbalance; however, central angiotensinergic
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circuits activated by subsequent exposure to a psychogenic
stressor may also be primed for heightened stimulation.
Pathways Mediating RAAS-Potentiated
Stress-Response
The RAAS has gained considerable attention over the past
decade as a potential therapeutic target for treating stress-related
disorders, anxiety, depression, alcoholism, cognitive impairment
as well as neuroinflammatory and neurodegenerative diseases
(Saavedra and Pavel, 2005; Albrecht, 2010; Saavedra, 2012; Anil
Kumar et al., 2014). Angiotensin receptor blockers administered
either peripherally or centrally, improve mood and cognition
as well as attenuate HPA axis and sympathetic responses
to stressors having strong psychogenic components (Saavedra
and Pavel, 2005; Albrecht, 2010; Saavedra, 2012; Anil Kumar
et al., 2014). While the specific circuits that angiotensin
receptor antagonists modulate to achieve these affects are
not fully understood, increased circulating Ang-II is known
to influence hypothalamic function through various pathways
including those originating in CVOs and regions governing
mood and affect.
Lamina Terminalis to Paraventricular Nucleus
The SFO and OVLT, together with the median preoptic nucleus
represent key regulatory areas that both share connectivity with
one another and project to the hypothalamus. As previously
discussed, the SFO and OVLT are unique in their ability to
sample the constituents of the systemic circulation and promote
activation of circuits to preserve homeostasis. Activation has
been shown to alter the balance between excitatory and inhibitory
projections to the PVH and SON which strongly influences the
activity of the HPA axis and behavior.
Excitation of PVH-mediated neuroendocrine and autonomic
regulation can be inhibited with the angiotensin-receptor
blocker losartan (Bains and Ferguson, 1993; Li and Ferguson,
1993). These studies also support the role of Ang-II acting as
a neurotransmitter specifically in an SFO to PVH circuit.
More recent investigation into the functionality of the
angiotensinergic SFO to PVH circuit found that while Ang-II
in the SFO significantly increased renal sympathetic nerve
activity and heart rate, inhibition of these effects could only be
accomplished by PVH pretreatment with glutamate (GLUT)
receptor antagonist and not losartan (Llewellyn et al., 2012).
Together, the results of these studies suggest that SFO to
PVH neurotransmission that is initiated by Ang-II binding
in the SFO may be either glutamatergic or angiotensinergic
depending on the stimulus. Indeed, on a cellular basis Ang-II
activation of AT1 receptors stimulates water intake or salt intake
through separate intracellular signaling pathways (Daniels et al.,
2009).
Hypovolemia-induced activation of the SFO and OVLT
influence local γ-amino butyric acid (GABA) and GLUT
circuits between these nuclei and the median preoptic nucleus
(Kolaj et al., 2004). The activity of GABA neurons projecting
from the SFO and OVLT to the median preoptic nucleus
is driven by hindbrain norepinephrine afferents to these
CVOs through activation of α-1 and α-2 adrenoreceptors
(Kolaj and Renaud, 2007). Antagonism of GABAA receptors
to model this inhibitory influence resulted in suppression
of hypotension-induced AVP release (Yamaguchi and Hama,
2011) suggesting that local inhibitory circuits originating
in the SFO and OVLT regulate the corresponding PVH
responses to stimuli that elevate systemic Ang-II. A similar
mechanism was modeled with an angiotensinergic OVLT
to SON circuit. Bourque et al. found that glutamatergic
osmosensitive neurons increased the output of AVP neurons,
but decreased the output of OT neurons in the presence
of Ang-II (Stachniak et al., 2014). Thus, while Ang-II
signaling in the periphery initiates compensatory circuits,
Ang-II acting as a neuromodulator is capable of tuning
appropriate GABAergic and glutamatergic inputs to the
hypothalamus.
The convergence of signaling through multiple osmosensitive
circuits results in behavioral changes and altered hypothalamic
regulation of stress-responsiveness. The behavioral outcome
of optogenetic stimulation of SFO afferents were recently
demonstrated in a dramatic way as excitatory projections
robustly increased thirst while inhibitory projections blocked
drinking behavior (Oka et al., 2015). Thirst as a result of
hypovolemia is associated with increased circulating Ang-II,
and activation of the pathways discussed above. Moreover,
acute hypotension increased Ang-II stimulated thirst, ACTH
and glucocorticoid release, and these increases were attenuated
by knocking-down AT1 receptors in the SFO, but not in the
OVLT (Krause et al., 2008). In a subsequent study, it was
determined that restraint-induced elevations in PRA and SFO
activation occurred with a time course commensurate with
those of ACTH and glucocorticoids (Krause et al., 2011b; See
Figure 1). Interrupting AT1 receptor expression in the SFO both
suppressed the HPA response and reduced anxiety-like behavior
(Krause et al., 2011b; See Figure 2). Furthermore, anterograde
tracer injection revealed SFO neurons making appositions onto
PVH neurons that were also activated by restraint (Krause et al.,
2011b), supporting the hypothesis that systemic Ang-II acts as
a stress hormone and anxiogenic agent through an SFO-PVH
connection.
Dorsal Raphe to Lamina Terminalis
Blocking Ang-II receptors improves mood and affect (Dimsdale,
1992) and there is anatomical and functional evidence that these
effects may be regulated, in part, by serotonin (5-HT). A bi-
directional connection exists between the SFO and the dorsal
raphe nucleus (DRN), the brain’s primary source of serotonin
(Lind, 1986). 5-HT released in the SFO has both excitatory and
inhibitory effects, and influences cells that are also sensitive to
Ang-II (Scrogin et al., 1998). Functionally, hypovolemia-induced
drinking is attenuated by i.c.v. pretreatment with a 5-HT1C/5-
HT2 agonist (Reis et al., 1992) and 5-HT1D agonist injected
into the 3rd ventricle reduces water intake in dehydrated rats
(De Castro-e-Silva et al., 1997) suggesting that serotonergic
innervation of the lamina terminalis is capable of disrupting the
dipsogenic effects of Ang-II. Caudal DRN neurons projecting
to the lamina terminalis are activated by urocortin-2 (Hale
et al., 2010), a stress and anxiety related neuropeptide that
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FIGURE 1 | Angiotensin receptor blockade attenuates restraint-induced
c-fos expression in the subfornical organ (SFO). (A) Sixty-minute restraint
elicits elevations in adrenocorticotropic hormone (ACTH), corticosterone
(CORT), and plasma renin activity (PRA) with similar peaks at 15 min (n = 8 per
group and time point). (B) Restraint significantly increases c-fos mRNA in the
SFO asterisk (*), different than 0 min; pound sign (#), different than 120 min;
*,#p < 0.05, n = 8 per group). (C) Restraint-induced c-fos mRNA expression in
the SFO is attenuated by systemic pretreatment with the AT1 receptor
antagonist losartan (*p < 0.05, n = 6 per group). Reprinted with permission
from Krause et al. (2011b).
FIGURE 2 | Inhibition of angiotensin type 1 (AT1) receptor
transcription in the SFO diminishes stress-responsiveness and
anxiety-like behavior. (A,B) Administration of a lentiviral antisense
(LV-AS) targeting an AT1 receptor coding region vs. lentiviral green
fluorescent protein expressing control (LV-GFP). Injection into the SFO
significantly decreases (*p < 0.05) the release of ACTH (A) and CORT
(B) during restraint (ACTH LV-GFP, n = 12; ACTH LV-AS, n = 12; CORT
LV-GFP, n = 16; CORT LV-AS, n = 15). (C,D) Delivery of LV-AS into the
SFO significantly increases (*p < 0.05) the amount of time spent in the
open arms of the elevated plus maze (EPM) but has no effect on total
distance traveled (n = 12 per group). Reprinted with permission from
Krause et al. (2011b).
binds to the CRF type-2 receptor and is generally thought
to produce anxiolytic effects. The beneficial mood-enhancing
effects of this pathway may be attenuated by activation of the
systemic RAAS, as release of 5-HT in the SFO is reduced in
the presence of Ang-II (Tanaka et al., 2003). Collectively, these
results suggest a complex interaction between Ang-II and 5-HT
in the SFO that may influence both water intake and anxiety
levels, and further research is needed to fully understand the
circuits by which anxiolysis is produced by blocking the effects
of Ang-II.
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Subfornical Organ to Bed Nucleus of the Stria
Terminalis (BNST) and Lateral Hypothalamus
The amygdala and bed nucleus of the stria terminalis
(BNST) are brain regions known to regulate the behavioral
and physiological responses to conditioned fear (Walker
et al., 2003). Ressler et al. recently found that systemic
administration of the AT1 receptor antagonist, losartan,
reduced Pavlovian fear-conditioning and decreased AT1
mRNA in the amygdala and BNST (Marvar et al., 2014).
Systemically delivered losartan is impermeable to the
blood-brain-barrier (Bui et al., 1992); however, peripheral
administration of losartan does antagonize AT1 receptors
residing in CVOs and suppresses stress-induced activation
of the SFO (Krause et al., 2011b). Similar to the PVH, the
BNST receives strong direct projections from SFO neurons
and it is possible that stress-induced elevations in blood-borne
Ang-II activates AT1 receptors expressed on SFO neurons to
influence neuronal activation within brain nuclei mediating
fear and anxiety. In this regard, systemic administration
of losartan decreased neuronal activation, as indicated by
c-fos mRNA, in the BNST subsequent to extinction of
conditioned fear (Marvar et al., 2014). The SFO is also
well-positioned to influence the cardiovascular response to
conditioned fear. The amygdala sends direct projections to
the lateral hypothalamus and this connection is implicated
in the cardiovascular responses to emotionally relevant
stimuli (Smith et al., 1990). The lateral hypothalamus sends
angiotensinergic projections to the SFO (Lind et al., 1985)
and pressor responses elicited by activation of amygdalar
connections to the lateral hypothalamus can be attenuated
by microinjections of angiotensin receptor antagonist into
the SFO (Ku and Li, 2003). Collectively, these results suggest
that AT1 receptor signaling within CVOs may influence
neuronal activation within limbic and hypothalamic nuclei,
which in turn, alters behavioral and physiological responses to
psychogenic stress.
Alternative Pathway of Angiotensin Signaling
A novel carboxypeptidase which shares 40% identity and
61% similarity with angiotensin-converting enzyme (ACE) was
discovered in 2000 (Tipnis et al., 2000). This ACE homolog
was named angiotensin-converting enzyme 2 (ACE2) based on
its ability to cleave Ang-II to produce angiotensin-(1-7) (Ang-
(1-7)) (Donoghue et al., 2000; Tipnis et al., 2000). Ang-(1-
7) counter-regulates many of the effects of the classic RAAS
through activation of the Mas receptor (Iwai and Horiuchi,
2009). Interestingly, the components of the ACE2/Ang-(1-
7)/Mas axis are expressed in brain regions which regulate
hydromineral balance and stress responsiveness including the
SFO, limbic system, PVH, NTS, and ventrolateral medulla
(Becker et al., 2007; Doobay et al., 2007). Thus, the counter-
regulatory limb of the RAAS is anatomically well-placed to
control hydromineral balance as well as stress responsiveness.
For example, ACE2 overexpression within the SFO blunts the
drinking and pressor responses elicited by centrally administered
Ang-II (Feng et al., 2008). The same study found that
ACE2 overexpression down-regulated AT1 receptor expression
in the SFO (Feng et al., 2008). AT1 receptor expressing
neurons in the SFO are thought to promote anxiety and
potentiate stress responsiveness through connections to the
PVH (Krause et al., 2011b). Therefore, it is possible that
the ACE2/Ang-(1-7)/Mas axis may have stress dampening
and anxiolytic effects through actions on the SFO and other
stress responsive brain nuclei. In this regard, rodents given
Ang-(1-7) i.c.v. demonstrate reduced anxiety-like behavior (Bild
and Ciobica, 2013) and attenuated cardiovascular responsiveness
to psychogenic stress (Martins Lima et al., 2013). Preliminary
results from our laboratory also suggest that manipulations that
up-regulate ACE2/Ang-(1-7)/Mas axis activity are anxiolytic and
stress dampening. Specifically, mice genetically engineered to
overexpress ACE2 exhibit suppressed anxiety-like behavior in
the elevated plus maze (EPM) and an attenuated glucocorticoid
response to restraint and these effects are eliminated by central
administration of a Mas receptor antagonist (Wang, 2013).
Currently, ACE2 is in clinical trials for the treatment of
cardiovascular andmetabolic disorders; however, the therapeutic
utility of targeting the ACE2/Ang-(1-7) axis for the alleviation
of mental health disorders may be only beginning to be
realized.
Summary
Real threats to body fluid homeostasis and perceived threats
derived from psychogenic origins activate the RAAS. Blood-
borne Ang-II stimulates AT1 receptors expressed on neurons
residing in CVOs and these neurons have direct connections
to hypothalamic and limbic nuclei controlling physiological
and behavioral responses to systemic and psychogenic stressors.
In addition, AT1 receptors are present on neurons within
the confines of the blood-brain barrier and their expression
is regulated by hydration state and stress exposure. These
AT1 receptors likely bind brain-derived Ang-II and influence
the function of neurons mediating hydromineral balance and
cardiovascular function as well as mood and affect. Looking
forward, in addition to AT1 receptors, it may be that brain renin,
angiotensinogen, or components of the ACE2/Ang-(1-7)/Mas
axis will need to be considered to fully realize the therapeutic
potential of targeting neuronal circuits that are influenced by
the RAAS.
Oxytocin, Vasopressin, and Stress
Responsiveness
The previous section discussed the neuronal circuits by which
the RAAS maintains body fluid homeostasis but also influences
the behavioral and physiological responses to psychogenic
stress. As mentioned, the major stimulus for RAAS activation
is sodium depletion or hyponatremia. However, excess body
sodium or hypernatremia is a potent inhibitor of the RAAS
and creates a distinct neural and humoral milieu that alleviates
elevations in body sodium levels. The following section reviews
the hypothalamic circuits that maintain hydromineral balance
when challenged with hypernatremia and discusses their overlap
and interactions with those that control stress responsiveness
and anxiety.
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FIGURE 3 | Acute hypernatremia reduces stress-responsiveness
and PRA, but increases plasma oxytocin (OT). (A) Restraint elevates
ACTH; however, rats treated with 2.0 M NaCl have a blunted response
compared with controls. (B) Similarly, restraint increases CORT, but rats
treated with 2.0 M NaCl have decreased CORT relative to controls.
(C) Restraint significantly increases PRA at 15 min for controls, but a
significant increase was not detected in rats given 2.0 M NaCl.
(D) Relative to controls, rats injected with 2.0 M NaCl have increased
systemic OT before and 30 and 60 min after the onset of restraint.
ACTH/CORT, n = 12 per condition; PRA/OT, n = 5–6 per time point.
***p < 0.01; *p < 0.05. Error bars indicate SEM. Reprinted with
permission from Krause et al. (2011a).
Neuropeptide Responses to Alleviate Elevated
Plasma Tonicity
The acute elevation of plasma tonicity that occurs following
hypertonic saline administration creates an osmotic gradient
which moves water from the intracellular fluid compartment
to the extracellular fluid, which in turn, increases blood
volume and pressure (Caeiro and Vivas, 2008). The loss of
water from the intracellular fluid compartment causes cell
shrinkage that is thought to activate osmoreceptors located
on the membrane of specialized osmosensitive cells. Research
investigating osmoreceptor function support the notion that
changes in membrane tension elicit conformational changes
in the osmoreceptor that lead to increased membrane ion
permeability, thereby transducing the change in osmolality
into a signaling mechanism that can affect other cells (Voisin
and Bourque, 2002; Bourque, 2008). Osmosensitive cells are
located in strategic areas including the throat (Kuramochi and
Kobayashi, 2000), intestines (Dooley and Valenzuela, 1984),
hepatic portal vein (Baertschi and Vallet, 1981) and CVOs in
the brain (McKinley et al., 1999). In regards to CVOs, the
OVLT conveys information regarding a change in osmolality
directly to AVP and OT producing cells in the SON and
PVH (Johnson and Gross, 1993). The release of AVP into the
systemic circulation counters the increased plasma osmolality by
promoting renal water retention. In rodents, the elevations in
systemic OT that follows hypernatremia promotes the inhibition
of renin release and stimulates renal sodium excretion (Sjöquist
et al., 1999). Thus, increased plasma osmolality due to excess
body sodium elicits activation of osmosensitive cells causing
subsequent release of neuropeptides into the systemic circulation
that alter the renal handling of sodium and water to alleviate
hypernatremia.
Hypernatremia-Induced Dampening of Stress
Responsiveness Through Hypothalamic Circuits
Recent investigation into the effects of hypertonic saline
injection on humoral, behavioral, and central measures of stress
responsiveness in male rats and mice revealed a prominent role
for activation of oxytocinergic pathways. Hypertonic (2.0 M)
saline injected s.c. followed by 60 min water deprivation
resulted in decreased ACTH, glucocorticoid, and PRA during
a 60 min restraint period, but significantly increased plasma
OT levels (Krause et al., 2011a; See Figure 3). Cardiovascular
recordings determined that rats rendered mildly hypernatremic
and subsequently exposed to restraint stress had mean arterial
pressure and heart-rate variability return to pre-restraint levels
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FIGURE 4 | Acute hypernatremia is associated with an
oxytocin-dependent inhibitory tone on putative stress-responsive
cells of the paraventricular nucleus. (A) Illustration of the change in
current density as observed during bath application of 1 µM OTR-A, an
oxytocin receptor antagonist. A decrease in current density is indicative of
removal of an inhibitory oxytocinergic tone but was observed only in slices
taken from hypernatremic rats. (B) Summary data for all cells that met criteria
for this experiment. Box plots for each group illustrate the mean (half-filled
circle), the median (horizontal line with in the box), and the SEM (top and
bottom edges of the box) are shown. The double asterisks over the 2.0 M
NaCl group indicate that the mean change in current density observed in this
group is significantly greater than 0 (p = 0.007) and also significantly greater
than the change observed in the 0.15 M NaCl group (p = 0.006). By
contrast, the mean change observed in the 0.15 M NaCl group was not
significantly different from 0 (p = 0.32). **p < 0.01. Reprinted with permission
from Frazier et al. (2013).
faster than normonatremic controls (Krause et al., 2011a).
Consistent with previous reports (Pirnik et al., 2004) acute
hypernatremia increased Fos induction in AVP and OT
expressing neurons in the PVH and SON, an effect that
was predictive of increased social interactions but decreased
anxiety-like behavior in the elevated plus maze (Krause et al.,
2011a). Acute hypernatremia and restraint stress interacted to
increase Fos expression in the OVLT, oval capsule of the BNST,
ventral lateral septum, and central nucleus of the amygdala
(Frazier et al., 2013). However, the increased neuronal activation
that occurred subsequent to acute hypernatremia and restraint
was specific to these brain regions as the medial pre-frontal
cortex, lateral ventral BNST, and dorsomedial hypothalamus
showed no significant change in Fos expression (Frazier et al.,
2013). Whole cell patch clamp recordings revealed that acute
hypernatremia caused inhibition of CRF neurons in the PVH
that was dependent on activation of OT receptors (Frazier
et al., 2013; Figure 4). Follow-up studies utilized the Cre-lox
system to generate a line of CRF reporter mice to investigate
the mechanisms underlying the anxiolysis and HPA dampening
that accompanies acute hypernatremia (Smith et al., 2014).
Acute hypernatremia elicited robust activation of OT neurons
in the PVH but attenuated the Fos induction that occurs
in CRF neurons subsequent to restraint stress (Smith et al.,
2014; See Figures 5, 6), suggesting that the oxytocinergic tone
that inhibited CRF neurons in electrophysiological experiments
suppresses stress-induced activation of CRF neurons in vivo.
Local Hypothalamic Circuits Regulated by Dendritic
Release of AVP and OT
Our laboratory and others (Huang et al., 2014) are actively
pursuing the neuronal mechanism underlying the dampened
HPA activation that occurs with acute hypernatremia. Seminal
studies conducted by Ludwig et al. discovered that subsequent
to the systemic release of AVP and OT that follows peripheral
salt-loading, brain levels of these neuropeptides exhibit a robust
and sustained increase (Ludwig et al., 1994). The implication
is that magnocellular neurons in the SON and PVH release
neuropeptides from dendrites and these neuropeptides may
act as autocrine or paracrine signals at their site of origin.
In this regard, dendritic release of AVP serves as a powerful
autocrine signal that modulates firing patterns and activity of
magnocellular AVP neurons in the SON and PVH (Ludwig
and Leng, 1997; Gouzènes et al., 1998). Recently dendritically
released neuropeptide also was found to signal in a paracrine
fashion to influence the functional activity of neighboring
neurons of a differing neuronal phenotype. Specifically, the Stern
laboratory discovered that dendritic release of AVP stimulated
neighboring presympathetic neurons in the PVH to drive
sympathoexcitation following a hyperosmotic stimulus (Son
et al., 2013). Hyperosmotic stimuli also trigger the dendritic
release of OT in the hypothalamus and (Ludwig and Leng,
2006; Mabrouk and Kennedy, 2012) OT neurons are in close
proximity to CRF neurons that express OT receptor mRNA
in the PVH (Dabrowska et al., 2011). Therefore, it is possible
that the inhibition of CRF neurons that accompanies acute
hypernatremia maybe regulated by dendritically released OT
that activates OT receptors expressed on CRF neurons in
the PVH.
Paraventricular and Supraoptic Nuclei of the
Hypothalamus to the Amygdala
Identifying the oxytocinergic circuits underlying the anxiolytic
effects of acute hypernatremia may reveal neuronal mechanisms
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FIGURE 5 | 2.0 M NaCl administration and restraint increases activation
of OT-producing cells in the paraventricular nucleus of the
hypothalamus (PVH). (A) Representative photomicrograph of a unilateral
coronal section depicting Fos induction (red nuclei) in OT (green cell bodies)
containing neurons following 0.15 M NaCl and restraint. (B) Representative
photomicrograph of a unilateral coronal section depicting Fos induction in OT
neurons following 2.0 M NaCl and restraint. (C) The group mean for Fos
induction in OT-producing cells was significantly more for mice subjected to
2.0 M NaCl injection and restraint relative to control. *p < 0.05 Scale
bars = 50 µm. Reprinted with permission from Smith et al. (2014).
FIGURE 6 | 2.0 M NaCl injection attenuates restraint-induced
activation of corticotrophin-releasing factor (CRF) neurons in a
transgenic reporter mouse. (A) Representative photomicrograph of a
unilateral coronal section through the PVH depicting Fos induction (cyan
nuclei) in tdTomato (red soma) containing neurons following 0.15 M
NaCl and restraint. (B) Representative photomicrograph of a unilateral
coronal section through the PVH depicting Fos induction in tdTomato
containing neurons following 2.0 M NaCl and restraint. (C) The group
mean for Fos induction in tdTomato containing neurons was significantly
less for mice subjected to 2.0 M NaCl injection and restraint relative to
control. *p < 0.05 Scale bars = 50 µm. Reprinted with permission from
Smith et al. (2014).
that quell excitation of neurons that facilitate physiological and
behavioral manifestations of fear and anxiety. The magnocellular
neurons in the PVH and SON are the major source of OT
but whether these neurons supplied OT to forebrain nuclei
controlling mood and affect was unclear because their axons are
known to terminate in the posterior pituitary where they release
OT into the systemic circulation. Consequently, endogenously
generated OT was hypothesized to activate OT receptors in
forebrain nuclei by diffusion of dendritically released peptide
(Ludwig and Leng, 2006) or via axonal release from a subset
of parvocellular oxytocinergic neurons residing in the PVH
that do not project to the pituitary (Swanson and Sawchenko,
1983). These hypotheses about the source of centrally released
OT have undergone a paradigm shift as the result of recent
research utilizing advanced techniques in neuroanatomical tract-
tracing. These elegant studies conducted by Grinevich et al.
discovered that OT neurons in the PVH and SON that
project to the posterior pituitary also send axon collaterals to
forebrain nuclei mediating stress responsiveness and anxiety-like
behavior (Knobloch et al., 2012). In other words, oxytocinergic
magnocellular neurons in the PVH and SON simultaneously
project to the posterior pituitary and the forebrain, presenting
the possibility that systemic and central release of OT maybe
accomplished by the same neurons. In rodents, magnocellular
oxytocinergic neurons in the PVH and SON are robustly excited
by elevations in the pNa+ (Krause et al., 2011a; Frazier et al.,
2013; Smith et al., 2014). Therefore, it is possible that acute
hypernatremia is a systemic stimulus that excites hypothalamic
osmosensing neurons to promote the release of OT into
systemic circulation, and subsequently, stimulates the release
of OT from axons terminating in forebrain nuclei known to
mediate physiological and behavioral manifestations of fear
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and anxiety. In support of this idea, ongoing studies suggest
that acute hypernatremia creates an inhibitory tone on CRF
neurons residing in the central nucleus of the amygdala that
is dependent on activation of OT receptors (Krause, 2014).
Amygdalar CRF neurons are implicated in the development
of anxiety disorders and further research is warranted to
determine whether this potential oxytocinergic pathway is a
viable therapeutic target.
Paraventricular Nucleus to the Bed Nucleus of the
Stria Terminalis
In addition to the central nucleus of the amygdala, the extensive
mapping of oxytocinergic afferents throughout the rat brain
isolated dense innervation of the BNST (Knobloch et al., 2012).
The BNST is a complex set of at least a dozen sub-nuclei that
mediate the information gathered by higher-order perceptual
and memory-based brain regions through an integrating process
involving the brain-stem and hypothalamus (Dong et al., 2001;
Bota et al., 2012). Because of this pivotal role, the BNST
is rich in neurochemical diversity, both locally and in terms
of the phenotype of afferent and efferent projections (Dong
and Swanson, 2006; Bota et al., 2012). Rainnie et al. used
viral anterograde tracing of PVH neurons to reveal that OT
immunoreactive fibers terminating in the BNST originate from
neurons in the PVH (Dabrowska et al., 2011) and subsequent
studies suggest that these cells are osmosensing magnocellular
neurons (Knobloch et al., 2012). Acute hypernatremia followed
by restraint-stress robustly activated OT neurons in the PVH
(Krause et al., 2011a; Smith et al., 2014) as well as neurons
residing in the oval capsule portion of the BNST (Frazier et al.,
2013). These studies support the hypothesis that elevations
in body sodium levels excite magnocellular OT neurons and
subsequent psychogenic stress exposure may trigger the release
of OT from axons terminating in the BNST, which in turn,
activate neurons within this nucleus. The pattern of neuronal
activation that occurs after acute hypernatremia and restraint
is predictive of decreased anxiety-like behavior and increased
social interactions (Krause et al., 2011a). In this regard, Kim
et al found that two BNST sub-regions have highly specific
roles in mediating separate features of anxiety such as risk-
avoidance and respiratory rate (Kim et al., 2013). While this
study found that activation of the BNST increased anxiety,
activation associated with acute hypernatremia seemed to be
related to a decrease in anxiety-like behavior. As mentioned, the
BNST is a highly diverse region in terms of cellular capabilities
and connectivity that may be the basis for understanding the
apparent discrepancies in activation of this region. Ultimately,
the circuit level data that has produced valuable insights
into the effects of activating cells in these areas will have
to be complemented by studies that take into consideration
ligand-receptor interactions.
Summary
An acute osmotic challenge induces anxiolytic and pro-social
effects associated with an increase in OT-producing cell
activation and a reduction in the HPA and behavioral
components of the stress response. As OT cells in the PVH are
both osmosensitive and receive projections from osmosensitive
areas of the brain, the increase in activation is likely due to the
pivotal role of OT in rectifying the fluid imbalance. Through
dendritic release and collateralized axonal projections that target
the posterior pituitary and limbic brain regions influencing
mood and behavior, OT signaling orchestrates the humoral
and behavioral responses necessary to maintain hydromineral
homeostasis specifically in the context of an acute hyperosmotic
stimulus.
Clinical Studies
Clinical correlates to the presented experimental findings using
animal models are abundant. Increased activity of the RAAS
is predictive of depression and anxiety, and when medication
that blocks or inhibits a specific component of the RAAS is
prescribed for hypertension, there has also been improvement in
mood and affect. Large scale studies have provided evidence that
ALDO levels may be a possible solution to the long-sought after
biomarker for affective disorders. Furthermore, direct evidence
for the anxiolytic and stress-dampening effects of OT is available
although there have been conflicting reports.
Renin-Angiotensin-Aldosterone System
Interest in the relationship between anxiety or depression
and RAAS activity found significant correlations. In a two-
year long study involving 1805 participants, researchers found
that depressed hypertensive individuals had elevated ALDO
levels compared with individuals that were not depressed
or those that were not hypertensive (Häfner et al., 2013).
Participants that were either only depressed or, surprisingly, only
hypertensive did not present with heighted renin or ALDO.
In a smaller, but much more specific study carried out while
participants were asleep, Murck et al. monitored HPA and
RAAS hormones of unmedicated depressed and age-matched
control subjects finding that ALDO was significantly higher in
depressed individuals (Murck et al., 2003, 2012). Furthermore,
more than half of patients with primary aldosteronism surveyed
also suffered from an anxiety disorder and these individuals
had higher levels of self-reported stress, psychological distress,
and a lower level of well-being (Sonino et al., 2006, 2011).
As previously discussed, ALDO affects specific areas of the
brain in rodent models, including the PVH, NTS, locus
coeruleus, and amygdala. The clinical data showing a correlation
between elevated ALDO with anxiety and depression suggests
that these areas are perhaps viable targets for intervention if
the primary cause of hyperaldosteronism cannot be directly
addressed.
Oxytocin
MacDonald and Feifel recently reviewed progress in developing
OT-based therapeutics, citing over 30 clinical studies using
intranasal administration of OT in normal individuals as well
as single and multi-dose trials in those suffering from a
brain-based illness (MacDonald and Feifel, 2014). Results in
terms of efficacy in reducing anxiety were conflicting; however,
some promising anatomical data was identified. For instance,
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FIGURE 7 | Circuits adapted in part from Ulrich-Lai and Herman
(2009) and Bourque (2008) demonstrating key hypothalamic circuits
that mediate the behavioral, endocrine, and autonomic
stress-response (shown in red and green). Many of these circuits are
also activated when the plasma osmolality is elevated above a threshold set
point (shown in blue and red). The circuits shown in red represent
stress-responsive pathways that may be altered during an osmotic
challenge such as hypernatremia. This figure is not exhaustive and does not
represent circuits that are necessarily monosynaptic. The borders and
relative size of each brain region were determined using Brain Explorer 2.1
SFO, subfornical organ; BNST, bed nuclei of the stria terminalis; MnPO,
median preoptic nucleus; OVLT, organum vasculosum of the lamina
terminalis; PVH, paraventricular nucleus of the hypothalamus; CeA, central
nucleus of the amygdala; SON, supraoptic nucleus; DRN, dorsal raphe
nucleus; aPit, anterior pituitary; pPit, posterior pituitary; NTS, nucleus of the
solitary tract; VLM, ventral lateral medulla.
females with a common OT receptor gene variant present with
a psychological phenotype that includes excessive worrying,
cautiousness, pessimism, shyness, and fearfulness (Wang et al.,
2014). This variant is associated with reduced resting state PFC
to amygdala connectivity as assessed by fMRI and this circuit’s
functional connectivity is improved with OT administration
(Dodhia et al., 2014). It may be that more specific routes of
altering the central OT system will be necessary in order to tailor
OT-based therapies to individual disorders.
A better understanding of the oxytocinergic circuitry may
lead to novel therapeutic strategies for treating core symptoms
of autism spectrum disorders (ASD). Anecdotal reports and
clinical case studies have found that illness accompanied by
fever markedly alleviates symptoms of ASD (Sullivan et al., 1980;
Cotterill, 1985; Curran et al., 2007). A hallmark of fever is
insensible water loss that causes acute hypernatremia or increases
in the plasma sodium concentration. Thus, it is plausible that
hypernatremia driven increases in central levels of endogenous
OT might alleviate symptoms of ASD. Accumulating preclinical
and clinical evidence suggests that brain oxytocinergic circuits
are valid candidate therapeutic targets for relief of ASD
symptoms (Andari et al., 2010; Guastella et al., 2010; Domes et al.,
2013; Taurines et al., 2014).
The ability of OT to suppress the activity of PVH CRF
neurons seems to be an effect seen in both humans and animal
models. As discussed previously, an acute hypernatremic state is
associated with increased central release of OT that potentiates
an inhibitory OT-dependent tone on CRF neurons of the PVH.
In support of this, human males were given intranasal OT
in a randomized, placebo-controlled, double-blind experiment
to test the effect on exercise-induced salivary cortisol levels
finding 24 IU, but not 48 IU OT significantly attenuated
cortisol levels compared with placebo (Cardoso et al., 2013).
Further research of this caliber is necessary to determine if
similar results are obtained with the induction of a psychogenic
stressor.
Closing Remarks
Relatively free, widespread access to potable water and an excess
of salt are contemporary additions to most civilized societies,
representing only a small fraction of human evolution. This
suggests that the hydration-related instincts that for millennia
guided behavior, may be as limited in their usefulness to modern
man as many misappropriated aspects of the stress response.
However, for many non-human species the centrally-mediated
mechanisms connecting hydromineral homeostasis with anxiety
levels may have developed to improve the likelihood of survival.
Activation of the RAAS is associated with physiological states
such as sodium and volume depletion, situations which would
also have the potential to produce an anxious state. For example,
species that do not consume meat have a dietary imperative to
locate and consume salt. Freely accessible salt may represent
isolated areas that may also be known to predators as a successful
hunting area. Thus, the low-sodium state and locating of a salt
source may be hazardous and necessitate the increased alertness
of heightened anxiety. Furthermore, a mild hypernatremic state
is relieved primarily by approaching a water source that may
also be frequented by a variety of species implying that the
increased sociability and decreased anxiety that accompanies
1http://mouse.brain-map.org/static/brainexplorer
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central OT release may be of survival value as well. It may be
that these evolutionarily conserved systems as well as the circuits
that interact with them may become dysregulated by a variety of
genetic and environmental influences.
The understanding of a pathological process obviously begins
with a clear understanding of normal physiological function.
Indeed, the development of our understanding of the RAAS
occupies a large segment of modern medical history which
has revolutionized pharmacological treatment for hypertension.
Pushing the boundaries of this knowledge has uncovered
local tissue-specific systems with RAAS components as well
as a counter-regulatory limb that will likely result in novel
therapeutic targets. Furthermore, it is clear that increased
activation of the RAAS promotes anxiety and potentiates the
response to a psychogenic stressor. While existing drugs have
been shown to improve these symptoms, it is still unclear
exactly how these off-target effects are accomplished. Similarly,
OT and AVP have well-characterized endocrine effects in the
body, but are just beginning to be thought of as centrally
acting mediators of behavior. Together, the mechanisms of
salt and water homeostasis represent a toolbox for uncovering
what may be fundamental central processes with unrealized
potential.
The primary advantages of studying the central effects of
both the RAAS and the neuropeptides OT and AVP is that
their systemic roles in normal physiological function have been
extensively studied and the routes by which they activate brain
circuits are well-understood (See Figure 7).With these rigorously
reviewed research findings at hand, it is possible to manipulate
the normal homeostatic mechanisms governing hydromineral
balance for the purpose of studying the effect on the brain
circuits involved. Often this can be accomplished without
the potential confounds of introducing a foreign substance
into the brain or facing the many drawbacks of injecting a
receptor blocker or agonist. Moreover, hydromineral balance is
primarily regulated by a complex series of behavioral adjustments
involving motivation, reward, social function, problem solving,
and risk assessment. Given the diversity and far-reaching
implications of these areas of research, there exists a translational
potential for basic science understanding targeted at further
revealing the mechanistic relationships between homeostatic and
stress-responsive systems.
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